Karen LaRochelle insider trades: PaxMedica (PXMD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Karen reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | PXMD | ↓ Sell | 78 | $0.48 | $37 | Direct | Jan 31, 2024 (2d) |
| Nov 27, 2023 | PXMD | ↓ Sell | 35 | $1.03 | $36 | Direct | Nov 29, 2023 (2d) |
| Oct 27, 2023 | PXMD | ↓ Sell | 1,679 | $0.19 | $317 | Direct | Oct 30, 2023 (3d) |
| Aug 29, 2023 | PXMD | ↓ Sell | 2,456 | $0.50 | $1K | Direct | Aug 30, 2023 (1d) |
| Mar 9, 2023 | PXMD | ↓ Sell | 335 | $1.48 | $496 | Direct | Mar 9, 2023 (0d) |
| Mar 3, 2023 | PXMD | ↓ Sell | 8,833 | $1.94 | $17K | Direct | Mar 3, 2023 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Karen LaRochelle's insider trades
Karen LaRochelle is a director at PaxMedica (PXMD). Since Mar 3, 2023, Karen has reported no open-market purchases and 6 sales worth $19K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (3 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PXMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.